Abstract
In recent years, ambient ionization mass spectrometry (AIMS) including laser ablation rapid evaporation IMS (LA-REIMS), has enabled direct biofluid metabolome analysis. AIMS procedures are however still hampered by both analytical, i.e., matrix effects, and practical, i.e., sample transport stability, drawbacks that impede metabolome coverage. In this study, we aimed at developing biofluid-specific metabolome sampling membranes (MetaSAMP®s) that offer a directly applicable and stabilizing substrate for AIMS. Customized rectal, salivary and urinary MetaSAMP®s consisting of electrospun nanofibrous membranes of blended hydrophilic (polyvinylpyrrolidone and polyacrylonitrile) and lipophilic (polystyrene) polymers supported metabolite ab-, ad-, and desorption. Moreover, MetaSAMP® demonstrated superior metabolome coverage and transport stability compared to crude biofluid analysis and was successfully validated in two pediatric cohorts (MetaBEAse, N=234 and OPERA, N=101). By integrating anthropometric and (patho)physiological with MetaSAMP®-AIMS metabolome data, we obtained significant weight-driven predictions and clinical correlations. In conclusion, MetaSAMP® holds great clinical application potential for on-the-spot metabolic health stratification.
Supplementary materials
Title
Supporting figures and tables
Description
Supporting figures and tables
Actions
Title
Data S1
Description
Data S1
Actions
Title
Data S2
Description
Data S2
Actions
Title
Data S3
Description
Data S3
Actions
Title
Data S4
Description
Data S4
Actions
Title
Data S5
Description
Data S5
Actions
Title
Data S6
Description
Data S6
Actions
Title
Data7
Description
Data S7
Actions
Title
Data S8
Description
Data S8
Actions